- Home
- Equipment
- asia middle east
- liver cancer
Refine by
Liver Cancer Equipment Supplied In Asia Middle East
6 equipment items found
Manufactured by:Boston Scientific based inMarlborough, MASSACHUSETTS (USA)
DC BeadM1 has been developed with a narrower distribution and offers the proven benefits of DC BeadM1 to more patients. Effective at penetrating metastatic tumors and avoiding premature proximal occlusion of tumour-feeding vessels. May allow for more concentrated drug delivery within the tumour and greater tumoural devascularisation. May allow the doctor to be more selective and target only the ...
Manufactured by:Boston Scientific based inMarlborough, MASSACHUSETTS (USA)
DC Bead is an embolic Drug-Eluting Bead capable of loading and releasing in a controlled manner chemotherapeutic agents. DC Bead is used in trans-arterial chemoembolisation (TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
BiomX develops phage cocktails (or combinations) that target and kill specific pathogenic bacteria. Our phage cocktails, which are optimized through algorithms and experimental validation (in-vitro and in-vivo), contain multiple natural and/or engineered phage. The phage are selected to have complementary functions such as wide target bacterial host range and the ability to avoid the development ...
Manufactured by:Optibio Co., Ltd. based inCheongju-si, SOUTH KOREA
Alpha-fetoprotein (AFP) is a major plasma protein produced primarily in the liver of a developing fetus. It can be found in maternal blood and in amniotic fluid since it is secreted into fetal serum. A great increase of AFP concentration in several malignant diseases mostly is primary hepatocellular carcinoma and non-seminoma testicular cancer. ...
Manufactured by:Pishtaz Teb Zaman Diagnostics based inGolestan Town, IRAN
Carcinoembroyonic antigen (CEA) is a 150300 kD glycoprotein molecule which has been found by Gold and Freedman at 1965 and it is also known as major component of CEA glycoprotein family. This family consists of 36 different glycoproteins with the common feature of close similarity of their structural domain to IgG heavy chain structure. Carbohydrate constitutes 45-55% of the CEA whole molecule ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 and older is projected to reach nearly 2.1 billion by 2050, versus 962 million in 2017.1 This means that the number of patients in all fields will be ...